WHO released the first clinical guidelines for tobacco cessation.
The guidelines focus on helping more than 750 million tobacco users who want to quit using tobacco products, according to a July 2 agency release. The organization recommends a comprehensive set of interventions, including behavioral support, digital interventions and pharmacological treatments.
More than 60% of tobacco users want to quit, but 70% lack access to effective cessation services, according to the release.
"This guideline marks a crucial milestone in our global battle against these dangerous products," Tedros Adhanom Ghebreyesus, PhD, WHO director general, said in the release. "It empowers countries with the essential tools to effectively support individuals in quitting tobacco and alleviate the global burden of tobacco-related diseases."
Treatment recommendations for tobacco cessation include varenicline, nicotine replacement therapy, bupropion, cytisine, and behavioral interventions, including brief health worker counseling and intensive behavioral support, as well as text messaging or self-management tools.